FDA Recalls · October 1, 2026 · Primary source
Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels
Summary
Greenwich Rx, a 503A compounding pharmacy in Tomball, Texas, issued a voluntary nationwide recall to the consumer level of specific lots of compounded glutathione due to potential elevated endotoxin levels. The recall was announced on October 1, 2026.
What this may mean
The recall affects specific lots of compounded glutathione distributed by a 503A pharmacy and is limited to those products. Patients and providers who received or dispensed the recalled lots face the product safety issue identified by the firm.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- FDA Recalls · October 7, 2026Nova Biomedical® Announces Global Medical Device Correction for StatStrip® Glucose Hospital MeterScore 48
- FDA Recalls · October 14, 2026Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate MatterScore 40
- FDA Recalls · October 10, 2026Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate MatterScore 40
- FDA Recalls · October 24, 2026Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency IssuesScore 32
- FDA Recalls · October 25, 2026Tonight We Ride, LLC Issues Voluntary Recall of Ultimate Forza Male Supplement Due to Presence of Undeclared Sildenafil, Tadalafil, and DapoxetineScore 30
- FDA Recalls · October 7, 2026Leader Formulas, LLC. Issues Voluntary Nationwide Recall of RAPTURE Preworkout Due to the Presence of 1,3-Dimethylamylamine (DMAA)Score 30